Matt Hancock and the UK government today gave a public thumbs up to Omega Diagnostics as it issued a press release that stated it had entered a partnership with Omega Diagnostics and Global Access Diagnostics.
While already known to many, the press release reemphasized the potential scale of the tests that could be manufacturing as it highlighted that both parties will combine to provide capacity for up to 200 million antigen tests.
Around 470 jobs are expected to created at the manufacturing sites of both Omega Diagnostics and Global Access Diagnostics.
The government also confirmed that both companies are expected to be able to produce up to 2 million tests per week by May, with Health Secretary Matt Hancock highlighting the importance of the lateral flow tests as he called Omega Diagnostics a great firm:
“Rapid lateral flow tests are essential to help us identify cases of the virus we otherwise wouldn’t find and preventing the virus spreading in our workplaces and communities.
These tests will help keep businesses open, our children return to school, people to visit their loved ones in care homes safely.
British innovation is at the forefront of our response to this pandemic and this partnership with 2 Great British firms will help us to build back better by tapping into the UK’s domestic talent, ingenuity and industry.”
Following the press release, Omega Diagnostics issued an after hours RNS in response to the official press release:
“We particularly welcome the government’s assistance to secure the specialist machinery needed to dramatically increase the scale of our manufacturing capacity which has allowed us to ensure a ready supply of high quality, reliable British made rapid lateral flow tests.“Colin King, CEO of Omega Diagnostics
What a difference a few hours makes!
What a difference a few hours makes…if only Omega Diagnostics tied the potential for a £374m contract with this news ( Is Omega Diagnostics just too honest for its own good? )